Large-scale, non-invasive methods for screening have been rendered feasible by salivaryimmunoglobulin A (IgA) and cytokines that promote inflammation, which serve as early indicators of viral infections like COVID-19 andHIV in the care of infectious diseases. The gene discussed is CD79A; the disease is COVID-19.